Ursodeoxycholic acid protects colon cancer HCT116 cells from deoxycholic acid-induced apoptosis by inhibiting apoptosome formation

Nutrition and Cancer

Volumn 64, Issue 4, 2012, Pages 617-626

  Saeki, Tohru ^a   Yui, Satoko ^a   Hirai, Tadashi ^a   Fujii, Takami ^a   Okada, Sawami ^a   Kanamoto, Ryuhei ^a  

^a KYOTO PREFECTURAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

APOPTOSOME; APOPTOTIC PROTEASE ACTIVATING FACTOR 1; BILE ACID; CASPASE 9; CYCLIC AMP; DEOXYCHOLIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROTEIN KINASE B; SECOND MITOCHONDRIAL ACTIVATOR OF CASPASE; URSODEOXYCHOLIC ACID; X LINKED INHIBITOR OF APOPTOSIS;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; APOPTOSOME FORMATION INHIBITION; ARTICLE; CANCER INHIBITION; CELL PROTECTION; CELL STRAIN HCT116; COLON CANCER; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN SECRETION; REACTION TIME; SIGNAL TRANSDUCTION;

APOPTOSIS; APOPTOSOMES; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; CASPASE 9; COLONIC NEOPLASMS; DEOXYCHOLIC ACID; HCT116 CELLS; HUMANS; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS C-AKT; URSODEOXYCHOLIC ACID; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 84861427468     PISSN: 01635581     EISSN: 15327914     Source Type: Journal    
DOI: 10.1080/01635581.2012.669876     Document Type: Article

References (35)

1. Faubion WA, Guicciardi ME, Miyoshi H, Bronk SF, Roberts PJ, et al.: Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas. J Clin Invest 103, 137-145, 1999. (Pubitemid 29031172)
2. Sodeman T, Bronk SF, Roberts PJ, Miyoshi H, and Gores GJ: Bile salts mediate hepatocyte apoptosis by increasing cell surface trafficking of Fas. Am J Physiol Gastrointest Liver Physiol 278, G992-G999, 2000. (Pubitemid 30439179)
3. Yui S,Kanamoto R, Iwami K, and Saeki T: Taurocholic acid does not induce apoptosis in HCT116 cells regardless of its intracellular concentration. Biosci Biotechnol Biochem 71, 800-802, 2007. (Pubitemid 46481439)
4. Higuchi H, Grambihler A, Canbay A, Bronk SF, and Gores GJ: Bile acids upregulate death receptor 5/TRAIL-receptor 2 expression via a c-Jun Nterminal kinase-dependent pathway involving Sp1.JBiol Chem279, 51-60, 2004. (Pubitemid 38044798)
5. Schlottman K, Wachs FP, Krieg RC, Kullmann F, Scholmerich J, et al.: Characterization of bile salt-induced apoptosis in colon cancer cell lines. Cancer Res 60, 4270-4276, 2000. (Pubitemid 30636616)
6. Wachs FP, Krieg RC, Rodrigues CM, Messmann H, Kullmann F, et al.: Bile salt-induced apoptosis in human colon cancer cell lines involves the mitochondrial transmembrane potential but not the CD95 (Fas/Apo-1) receptor. Int J Colorectal Dis 20, 103-113, 2005. (Pubitemid 40227516)
7. Yui S, Saeki T, Kanamoto R, and Iwami K: Characteristics of apoptosis in HCT116 colon cancer cells induced by deoxycholic acid. J Biochem 138, 151-157, 2005. (Pubitemid 41265365)
8. Yui S, Kanamoto R, and Saeki T: Biphasic regulation of cell death and survival by hydrophobic bile acids in HCT116 cells. Nutr Cancer 61, 374-380, 2009.
9. Rodrigues CM, Fan G, Ma X, Kren BT, and Steer CJ: A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J Clin Invest 101, 2790-2799, 1998. (Pubitemid 28294588)
10. Rodrigues CM, Fan G,Wong PY, Kren BT, and Steer CJ: Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production. Mol Med 4, 165-178, 1998. (Pubitemid 28223968)
11. Amaral JD, Castro RE, Sola S, Steer CJ, and Rodrigues CM: p53 is a key molecular target of ursodeoxycholic acid in regulating apoptosis. J Biol Chem 282, 34250-34259, 2007. (Pubitemid 350159473)
12. Sola S, Ma X, Castro RE, Kren BT, Steer CJ, et al.: Ursodeoxycholic acid modulates E2F-1 and p53 expression through a caspase-independent mechanism in transforming growth factor beta1-induced apoptosis of rat hepatocytes. J Biol Chem 278, 48831-48838, 2003.
13. Im E and Martinez JD: Ursodeoxycholic acid (UDCA) can inhibit deoxycholic acid (DCA)-induced apoptosis via modulation of EGFR/Raf-1/ERK signaling in human colon cancer cells. J Nutr 134, 483-486, 2004. (Pubitemid 38141837)
14. Im E, Akare S, Powell A, and Martinez JD: Ursodeoxycholic acid can suppress deoxycholic acid-induced apoptosis by stimulating Akt/PKBdependent survival signaling. Nutr Cancer 51, 110-116, 2005. (Pubitemid 40365989)
15. Holzinger F, Schteingart CD, Ton-Nu HT, Eming SA, Monte MJ, et al.: Fluorescent bile acid derivatives: relationship between chemical structure and hepatic and intestinal transport in the rat. Hepatology 26, 1263-1271, 1997. (Pubitemid 27509312)
16. Eckelman BP, Salvesen GS, and Scott FL: Human inhibitor of apoptosis proteins: whyXIAP is the black sheep of the family.EMBORep 7 988-994 2006. (Pubitemid 44480512)
17. Allan LA and Clarke PR: Phosphorylation of caspase-9 by CDK1/cyclin B1 protects mitotic cells against apoptosis. Mol Cell 26, 301-310, 2007. (Pubitemid 46617338)
18. Allan LA, Morrice N, Brady S, Magee G, Pathak S, et al.: Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK. Nat Cell Biol 5, 647-654, 2003. (Pubitemid 36818087)
19. Seifert A, Allan LA, and Clarke PR: DYRK1A phosphorylates caspase 9 at an inhibitory site and is potently inhibited in human cells by harmine. FEBS J 275, 6268-6280, 2008.
20. Seifert A and Clarke PR: p38alpha-and DYRK1A-dependent phosphorylation of caspase-9 at an inhibitory site in response to hyperosmotic stress. Cell Signal 21, 1626-1633, 2009.
21. Azzaroli F, Mehal W, Soroka CJ, Wang L, Lee J, et al.: Ursodeoxycholic acid diminishes Fas-ligand-induced apoptosis in mouse hepatocytes. Hepatology 36, 49-54, 2002. (Pubitemid 34700761)
22. Iwaki T, Ishizaki K, Kinoshita S, Tanaka H, Fukunari A, et al.: Protective effects of ursodeoxycholic acid on chenodeoxycholic acid-induced liver injury in hamsters. World J Gastroenterol 13, 5003-5008, 2007. (Pubitemid 47496834)
23. Rodrigues CM, Ma X, Linehan-Stieers C, Fan G, Kren BT, et al.: Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation. Cell Death Differ 6, 842-854, 1999. (Pubitemid 29488082)
24. Schoemaker MH, Conde de la Rosa L, Buist-Homan M, Vrenken TE, Havinga R, et al.: Tauroursodeoxycholic acid protects rat hepatocytes from bile acid-induced apoptosis via activation of survival pathways. Hepatology 39, 1563-1573, 2004. (Pubitemid 38702657)
25. Sola S, Amaral JD, Borralho PM, Ramalho RM, Castro RE, et al.: Functional modulation of nuclear steroid receptors by tauroursodeoxycholic acid reduces amyloid beta-peptide-induced apoptosis. Mol Endocrinol 20, 2292-2303, 2006. (Pubitemid 44496402)
26. Martinez JD, Stratagoules ED, LaRue JM, Powell AA, Gause PR, et al.: Different bile acids exhibit distinct biological effects: the tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferation. Nutr Cancer 31, 111-118, 1998. (Pubitemid 28428071)
27. Powell AA, LaRue JM, Batta AK, andMartinez JD: Bile acid hydrophobicity is correlated with induction of apoptosis and/or growth arrest in HCT116 cells. Biochem J 356, 481-486, 2001. (Pubitemid 32532359)
28. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, et al.: Regulation of cell death protease caspase-9 by phosphorylation. Science 282, 1318-1321, 1998. (Pubitemid 28524494)
29. Rajesh KG, Suzuki R, Maeda H, Yamamoto M, Yutong X, et al.: Hydrophilic bile salt ursodeoxycholic acid protects myocardium against reperfusion injury in a PI3K/Akt dependent pathway. J Mol Cell Cardiol 39, 766-776, 2005. (Pubitemid 41464413)
30. Rust C, Bauchmuller K, Fickert P, Fuchsbichler A, and Beuers U: Phosphatidylinositol 3-kinase-dependent signalingmodulates taurochenodeoxycholic acid-induced liver injury and cholestasis in perfused rat livers. Am J Physiol Gastrointest Liver Physiol 289, G88-G94, 2005. (Pubitemid 40944227)
31. Crowley-Weber CL, Payne CM, Gleason-Guzman M, Watts GS, Futscher B, et al.:Development and molecular characterization ofHCT-116 cell lines resistant to the tumor promoter and multiple stress-inducer, deoxycholate. Carcinogenesis 23, 2063-2080, 2002. (Pubitemid 36109121)
32. Earnest DL, Holubec H, Wali RK, Jolley CS, Bissonette M, et al.: Chemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid. Cancer Res 54, 5071-5074, 1994.
33. Khare S,Mustafi R, Cerda S, YuanW, Jagadeeswaran S, et al.: Ursodeoxycholic acid suppresses Cox-2 expression in colon cancer: roles of Ras, p38, and CCAAT/enhancer-binding protein. Nutr Cancer 60, 389-400, 2008. (Pubitemid 351601376)
34. Shah SA, Looby E, Volkov Y, Long A and Kelleher D: Ursodeoxycholic acid inhibits translocation of protein kinase C in human colonic cancer cell lines. Eur J Cancer 41, 2160-2169, 2005. (Pubitemid 41337959)
35. Shah SA, Volkov Y, Arfin Q, Abdel-Latif MM, and Kelleher D: Ursodeoxycholic acid inhibits interleukin 1 beta [corrected] and deoxycholic acidinduced activation of NF-kappaB and AP-1 in human colon cancer cells. Int J Cancer 118, 532-539, 2006. (Pubitemid 43076000)